 Home > Medical News > Latest Medical News > Shanghai Pharmaceuticals SPH3127 Tablets New Indication Approved for Clinical Clinic

Shanghai Pharmaceuticals SPH3127 Tablets New Indication Approved for Clinical Clinic

 Last Update: 2021-06-02
 Source: Internet
 Author: User

Tags

what purpose food drug administration

drug hypersensitivity

singulair drug interactions

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On May 19, Shanghai Pharmaceuticals issued an announcement stating that the clinical trial application for the development of "SPH3127 tablets" for chronic kidney disease indications was officially accepted by the State Food and Drug Administration.

SPH3127 tablets are a new type of oral renin inhibitor.

This drug application intends to carry out clinical trials with chronic kidney disease as the indication.

Up to now, the project has invested a total of RMB 7.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.